Brunei Darussalam vs Developing regions: Proportion of the target population who received the final dose of
Brunei Darussalam
88.0%
in 2024
Developing regions
26.0%
in 2024
Brunei Darussalam rank
14th
Developing regions rank
24th
Proportion of the target population who received the final dose of over time
- Brunei Darussalam
- Developing regions
How they compare
Brunei Darussalam currently reports 88.0% against 26.0% in Developing regions, a difference of 62.0%.
That makes Brunei Darussalam's figure about 3.4 times Developing regions's.
Across all 13 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 14th and Developing regions ranks 24th of 107 countries.
Brunei Darussalam has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 84.8% | 6.6% | 78.1% | Brunei Darussalam |
| 2020s | 88.2% | 14.0% | 74.2% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Brunei Darussalam or Developing regions?
- Brunei Darussalam, at 88.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Brunei Darussalam and Developing regions?
- 62.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Developing regions?
- 13 years are reported by both, from 2012 to 2024.
- How do Brunei Darussalam and Developing regions rank globally for proportion of the target population who received the final dose of?
- Brunei Darussalam ranks 14th and Developing regions ranks 24th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.